MedPath

Study of the effect of black garlic on immunity and coagulation in healthy volunteers

Phase 2
Completed
Conditions
Immunity
Registration Number
TCTR20210610001
Lead Sponsor
Department of Pharmacology, Faculty of Medicine, Chiang Mai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
15
Inclusion Criteria

Male and female Healthy volunteer aged 20-45 years;
No significant underlying disease;
All patients will be informed both verbally and in writing of the possible risks and adverse events which may occur during the study and must sign the written consent forms to participate in the study.

Exclusion Criteria

Abnormal finding after physical examination
BMI more than or equal to 25 kg/m2
Clinically significant abnormalities in blood chemistry and hematology:
oHemoglobin < 10 g/dL
oWhite blood cells < 4,000 per cu. mm.
oPlatelets < 100,000 per cu. mm.
oAlanine aminotransferase (ALT), aspartate aminotransferase (AST), or alkaline phosphatase more than 2 times the upper limit of normal
oBlood urea nitrogen (BUN) more than 20 mg/dL, creatinine more than 1.5 times the upper limit of normal
oAbnormal urine examination
oProthrombin time (PT) more than 13.0 sec, international normalized ratio (INR) more than 5, or partial thromboplastin time (PTT) more than 38.9 sec
Unable to participate throughout the study period
Have a history of hypersensitivity to garlic or black garlic
Smoking
Pregnant or lactating;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cytokines Day 0, 1, 28, 56 ELISA,White blood cells Day 0, 1, 28, 56 Flow cytometry
Secondary Outcome Measures
NameTimeMethod
Platelet aggregation Day 0, 28, 56 Platelet aggregometry,Coagulation Day 0, 28, 56 PT, PTT, INR,Safety Day 0, 14, 28, 56 CBC, BUN, Cr, LFT, U/A,VASP Day 0, 28, 56 VASP phosphorylation assay
© Copyright 2025. All Rights Reserved by MedPath